Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Vitreoretinal Diseases|November 6, 2023
Opportunity Cost of Vitreoretinal SurgeriesElla H Leung, Shriji Patel, Rahul Reddy, et al.Ophthalmology. Retina|June 21, 2024
Risk of Proliferative Vitreoretinopathy in the Second Eye in Adult Patients with Bilateral Retinal DetachmentE Anne Shepherd, Samuel A Minaker, Prithvi R Bomdica, et al.Ophthalmology. Retina|October 10, 2025
Analysis of Fellow Eye Posterior Vitreous Detachment and Complications Using a Large Database of Retina SpecialistsJohn Brown, Curtis Heisel, Nick Boucher, et al.Ophthalmology. Retina|May 5, 2023
Levodopa Is Associated with Reduced Development of Neovascular Age-Related Macular DegenerationMax J Hyman, Dimitra Skondra, Nitika Aggarwal, et al.Journal of Vitreoretinal Diseases|April 3, 2023
Opportunity Cost of Retinal Detachment Surgery vs Office-Based Patient CareElla H Leung, Henry A Leder, Shriji Patel, et al.Ophthalmology. Retina|May 29, 2025
Treatment Patterns and Long-term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum DatabaseMichael Ip, Yasha Modi, Sharon Fekrat, et al.Retina (Philadelphia, Pa.)|February 17, 2022
REGIONAL POPULATION MOBILITY AND OUTPATIENT RETINA VISITS IN THE UNITED STATES DURING THE COVID-19 PANDEMICRebecca R Soares, Charles Huang, Nick Boucher, et al.Journal of Vitreoretinal Diseases|August 14, 2025
Cost-Effectiveness of Treatments for Diabetic Macular Edema: Simulated Bevacizumab-First Step Therapy Versus Real-World PracticeElla H Leung, Dilraj S Grewal, Emanuel Gerbi, et al.Journal of Vitreoretinal Diseases|November 14, 2024
Bevacizumab First in DRCR Protocol AC vs Real-World Physician Treatment Choice for Diabetic Macular Edema: Two-Year Cost AnalysisDilraj S Grewal, Ella Leung, Miguel Busquets, et al.Pageof 3